Macrophage migration inhibitory factor is a direct target of HBP1-mediated transcriptional repression that is overexpressed in prostate cancer

Oncogene

Volumn 29, Issue 21, 2010, Pages 3067-3078

  Chen, Y C ^a   Zhang, X W ^b   Niu, X H ^a   Xin, D Q ^a   Zhao, W P ^c   Na, Y Q ^a   Mao, Z B ^b  

^a PEKING UNIVERSITY FIRST HOSPITAL   (China)

^b PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^c ZHEJIANG UNIVERSITY   (China)

Author keywords

Cancer; HBP1; MIF

Indexed keywords

DNA; MACROPHAGE MIGRATION INHIBITION FACTOR; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR HMG BOX CONTAINING PROTEIN 1; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; CANCER GROWTH; CANCER INHIBITION; CANCER INVASION; CANCER RELAPSE; CANCER SURVIVAL; CLINICAL ARTICLE; COMPUTER ANALYSIS; CONTROLLED STUDY; DNA BINDING; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENE REPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN TISSUE; IN VIVO STUDY; MALE; NEGATIVE FEEDBACK; PRIORITY JOURNAL; PROMOTER REGION; PROSTATE CANCER;

ANIMALS; BINDING SITES; DNA, NEOPLASM; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, REPORTER; HUMANS; LUCIFERASES; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MALE; NUCLEAR PROTEINS; PROSTATIC NEOPLASMS; RECURRENCE; TRANSCRIPTION, GENETIC; TRANSFECTION;

EID: 77952952403     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2010.97     Document Type: Article

References (27)

1. Berasi SP, Xiu M, Yee AS, Paulson KE. (2004). HBP1 repression of the p47phox gene: cell cycle regulation via the NADPH oxidase. Mol Cell Biol 24: 3011-3024.
2. Bini L, Magi B, Marzocchi B, Arcuri F, Tripodi S, Cintorino M et al. (1997). Protein expression profiles in human breast ductal carcinoma and histologically normal tissue. Electrophoresis 18: 2832-2841.
3. Gartel AL, Goufman E, Tevosian SG, Shih H, Yee AS, Tyner AL. (1998). Activation and repression of p21(WAF1/CIP1) transcription by RB binding proteins. Oncogene 17: 3463-3469.
4. Hudson JD, Shoaibi MA, Maestro R, Carnero A, Hannon GJ, Beach DH. (1999). A proinflammatory cytokine inhibits p53 tumor suppressor activity. J Exp Med 190: 1375-1382.
5. Kamimura A, Kamachi M, Nishihira J, Ogura S, Isobe H, Dosaka-Akita H et al. (2000). Intracellular distribution of macrophage migration inhibitory factor predicts the prognosis of patients with adenocarcinoma of the lung. Cancer 89: 334-341.
6. Lavender P, Vandel L, Bannister AJ, Kouzarides T. (1997). The HMG-box transcription factor HBP1 is targeted by the pocket proteins and E1A. Oncogene 14: 2721-2728.
7. Lemercier C, Duncliffe K, Boibessot I, Zhang H, Verdel A, Angelov D et al. (2000). Involvement of retinoblastoma protein and HBP1 in histone H1(0) gene expression. Mol Cell Biol 18: 6627-6637.
8. Li Y, Welm B, Podsypanina K, Huang S, Chamorro M, Zhang X et al. (2003). Evidence that transgenes encoding components of the Wnt signaling pathway preferentially induce mammary cancers from progenitor cells. Proc Natl Acad Sci USA 100: 15853-15858.
9. Lin KM, Zhao WG, Bhatnagar J, Zhao WD, Lu JP, Simko S et al. (2001). Cloning and expression of human HBP1, a high mobility group protein that enhances myeloperoxidase (MPO) promoter activity. Leukemia 15: 601-612.
10. Liu BY, McDermott SP, Khwaja SS, Alexander CM. (2004). The transforming activity of Wnt effectors correlates with their ability to induce the accumulation of mammary progenitor cells. Proc Natl Acad Sci USA 101: 4158-4163.
11. Lu XF, Jiang XG, Lu YB, Bai JH, Mao ZB. (2005). Characterization of a novel positive transcription regulatory element that differentially regulates the insulin-like growth factor binding protein-3 (IGFBP-3) gene in senescent cells. J Biol Chem 280: 22606-22615.
12. Meyer-Siegler K, Hudson PB. (1996). Enhanced expression of macrophage migration inhibitory factor in prostatic adenocarcino-ma metastases. Urology 48: 448-452.
13. Meyer-Siegler KL, Leifheit EC, Vera PL. (2004). Inhibition of macrophage migration inhibitory factor decreases proliferation and cytokine expression in bladder cancer cells. BMC Cancer 4: 34.
14. Mitchell RA. (2004). Mechanisms and effectors of MIF-dependent promotion of tumourigenesis. Cell Signal 16: 13-19.
15. Paulson KE, Kimberly RC, McDevitt MA, Kuperwasser C, Kim J, Vincent E et al. (2007). Alterations of the HBP1 transcriptional repressor are associated with invasive breast cancer. Cancer Res 67: 6136-6145.
16. Petrenko O, Fingerle-Rowson G, Peng T, Mitchell RA, Metz CN. (2003). Macrophage migration inhibitory factor deficiency is associated with altered cell growth and reduced susceptibility to Ras-mediated transformation. J Biol Chem 278: 11078-11085.
17. Ren Y, Tsui HT, Poon RT, Ng IO, Li Z, Chen Y et al. (2003). Macrophage migration inhibitory factor: roles in regulating tumor cell migration and expression of angiogenic factors in hepatocellular carcinoma. Int J Cancer 107: 22-29.
18. Reya T, Clevers H. (2005). Wnt signalling in stem cells and cancer. Nature 434: 843-850. (Pubitemid 40558990)
19. Sampson EM, Haque ZK, Ku MC, Tevosian SG, Albanese C, Pestell RG. (2001). Negative regulation of the Wnt-beta-catenin pathway by the transcriptional repressor HBP1. EMBO J 20: 4500-4511.
20. Shang Y, Myers M, Brown M. (2002). Formation of the androgen receptor transcription complex. Mol Cell 9: 601-610.
21. Shih HH, Tevosian SG, Yee AS. (1998). Regulation of differentiation by HBP1, a target of the retinoblastoma protein. Mol Cell Biol 18: 4732-4743.
22. Shimizu T, Abe R, Nakamura H, Ohkawara A, Suzuki M, Nishihira J. (1999). High expression of macrophage migration inhibitory factor in human melanoma cells and its role in tumor cell growth and angiogenesis. Biochem Biophys Res Commun 264: 751-758.
23. Tevosian SG, Shih HH, Mendelson KG, Sheppard KA, Paulson KE, Yee AS. 1997)). HBP1: a HMG box transcriptional repressor that is targeted by the retinoblastoma family. Genes 11: 383-396.
24. Walsh PC. (2002). Campbell's Urology. Elsevier Science: USA.
25. Yee AS, Paulson EK, McDevitt MA, Rieger-Christ K, Summerhayes I, Berasi SP et al. (2004). The HBP1 transcriptional repressor and the p38 MAP kinase: unlikely partners in G1 regulation and tumor suppression. Gene 336: 1-13.
26. Zhang X, Kim J, Ruthazer R, McDevitt MA, Wazer DE, Paulson KE et al. (2006). The HBP1 transcriptional repressor participates in RAS-induced premature senescence. Mol Cell Biol 26: 8252-8266.
27. Zhuma T, Tyrrell R, Sekkali B, Skavdis G, Saveliev A, Tolaini M et al. (1999). Human HMG box transcription factor HBP1: a role in hCD2LCR function. EMBO J 18: 6396-6406.